Application 215316
- Type
- ANDA
- Sponsor
- QILU
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | DAPTOMYCIN | DAPTOMYCIN | POWDER;INTRAVENOUS | 500MG/VIAL | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 60505-6229 | Daptomycin | Daptomycin | APOTEX CORP. | ANDA | Current |
| 60505-6229 | Daptomycin | Daptomycin | APOTEX CORP. | ANDA | Current |
| 60505-6229 | Daptomycin | Daptomycin | APOTEX CORP. | ANDA | Current |
| 67184-0549 | Daptomycin | Daptomycin | Qilu Pharmaceutical Co., Ltd. | ANDA | Current |
| 67184-0549 | Daptomycin | Daptomycin | Qilu Pharmaceutical Co., Ltd. | ANDA | Current |
| 67184-0549 | Daptomycin | Daptomycin | Qilu Pharmaceutical Co., Ltd. | ANDA | Current |